Vident Investment Advisory, LLC - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 130 filers reported holding TRILLIUM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.

Quarter-by-quarter ownership
Vident Investment Advisory, LLC ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$2,639,000
+69.0%
150,259
-6.7%
0.08%
+70.2%
Q2 2021$1,562,000
+6.3%
160,991
+17.7%
0.05%
-4.1%
Q1 2021$1,469,000
-26.4%
136,785
+0.7%
0.05%
-39.5%
Q4 2020$1,997,000
-18.4%
135,779
-21.1%
0.08%
-33.6%
Q3 2020$2,447,000
+70.8%
172,145
-2.8%
0.12%
+62.7%
Q2 2020$1,433,000177,1000.08%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
VR Adviser, LLC 4,040,000$59,428,0008.74%
Fairmount Funds Management LLC 1,478,181$21,744,0007.78%
COMMODORE CAPITAL LP 852,871$12,546,0006.82%
Ghost Tree Capital, LLC 1,950,000$28,685,0006.39%
Endurant Capital Management LP 655,741$9,646,0003.48%
FRAZIER MANAGEMENT LLC 3,053,107$44,879,0003.46%
ACUTA CAPITAL PARTNERS, LLC 803,000$11,812,0003.21%
NEA Management Company, LLC 5,736,363$84,382,0002.23%
Tri Locum Partners LP 296,838$4,366,0001.59%
Avidity Partners Management LP 3,185,200$46,854,0001.52%
View complete list of TRILLIUM THERAPEUTICS INC shareholders